ANP32B and acute myeloid leukemia: Consequently, it can be inferred that ANP32B, acting as a super enhancer, potentially regulate the expression of MYC via epigenetic regulation of histone acetylation, thereby impacting the occurrence and progression of AML (Fig. 7G).